Yayınlar & Eserler

Yayın Ağı
Makaleler 19
Tümü (19)
SCI-E, SSCI, AHCI (16)
SCI-E, SSCI, AHCI, ESCI (19)
ESCI (3)
Scopus (19)
TRDizin (1)

1. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines

Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.
Journal of Drug Delivery Science and Technology , cilt.79, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

2. Plasma irisin and metabolomic response differ between concentric and isometric exercise Effets différents de l'exercice concentrique et de l'exercice isométrique sur l'irisine plasmatique et la réponse métabolomique

KARA Ö. S., ERCAN A., ÇELEBİER M., KAPLAN O., ÖNCÜL S., KORKUSUZ F.
Science and Sports , cilt.37, sa.7, ss.610-617, 2022 (SCI-Expanded, Scopus) identifier identifier

3. Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.
Current Pharmaceutical Analysis , cilt.17, sa.10, ss.1272-1281, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

4. An investigation of the effect of surface characterization on Saos-2 cell proliferation after coating of titanium alloy surfaces by a selective laser melting process

Olcay E. O., ERCAN A., ÖNCÜL S., Arifagaoglu O., ERSU B.
Surface and Coatings Technology , cilt.422, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

5. Antitumor activity of Ankaferd Blood Stopper (R) on MCF-7 breast cancer: A proteomic approach to ascertain the mechanism of the action

Zeki O. C., NENNİ M., ÇELEBİER M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., et al.
JOURNAL OF HERBAL MEDICINE , cilt.28, 2021 (SCI-Expanded, Scopus) identifier identifier

6. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level

ERCAN A., ÇELEBİER M., ÖNCÜL S., VARAN G., KOÇAK E., Benito J. M., et al.
International Journal of Pharmaceutics , cilt.598, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

7. Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper (R) Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies

NENNİ M., ÖNCÜL S., ERCAN A., ÇELEBİER M., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
CURRENT TRADITIONAL MEDICINE , cilt.7, sa.2, ss.223-235, 2021 (ESCI, Scopus) identifier identifier

8. An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes

ERCAN A., ÖNCÜL S., Karakaya G., Aytemir M.
BIOORGANIC CHEMISTRY , cilt.105, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum

Oncul S., Amero P., Rodriguez-Aguayo C., Calin G. A., Sood A. K., Lopez-Berestein G.
RNA BIOLOGY , cilt.17, sa.11, ss.1523-1534, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. The interaction between the complement system and hemostatic factors

ÖNCÜL S., Afshar-Kharghan V.
CURRENT OPINION IN HEMATOLOGY , cilt.27, sa.5, ss.341-352, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

11. Comparison of cell lysis techniques via q-tof lc/ms

KAPLAN O., ÖNCÜL S., ERCAN A., ÇELEBİER M.
Mass Spectrometry Letters , cilt.11, sa.2, ss.36-40, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

12. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance

ÖNCÜL S., Karakaya G., Dilsiz Aytemir M., ERCAN A.
Chemical Biology and Drug Design , cilt.94, sa.6, ss.2084-2093, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

13. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives

Karakaya G., TÜRE A., ERCAN A., ÖNCÜL S., Aytemir M.
Bioorganic Chemistry , cilt.88, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

14. HGF-1 proliferation on titanium dental implants treated with laser melting technology

Arifagaoglu O., ÖNCÜL S., ERCAN A., Olcay O., ERSU B.
NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.22, sa.2, ss.251-257, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Kojic acid derivatives as potential anticancer agents: Synthesis and cytotoxic evaluation on A375 human malignant melanoma cells

Karakaya G., ERCAN A., ÖNCÜL S., Aytemir M.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.4, ss.596-607, 2019 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

16. Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells

KARAKAYA G., ÖNCÜL S., ERCAN A., AYTEMİR M.
Anti-Cancer Agents In Medicinal Chemistry , cilt.18, ss.1-12, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

17. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.
European Journal of Pharmaceutical Sciences , cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. Discrimination of the Effects of Doxorubicin on Two Different Breast Cancer Cell Lines on Account of Multidrug Resistance and Apoptosis

ÖNCÜL S., ERCAN A.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.79, sa.4, ss.599-607, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

19. Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles

VARAN G., ÖNCÜL S., ERCAN A., BENITO J. M., MELLET C. O., BİLENSOY E.
Journal of Pharmaceutical Sciences , cilt.105, sa.10, ss.3172-3182, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 18

1. Proteomic Investigation of Ankaferd Hemostat Application on MCF-7 Breast Cancer Cell Line

ZEKİ Ö. C., NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
International Multidisciplinary Symposium on Drug Research and Development (DRD), 1 - 03 Temmuz 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

2. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.
EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Breast cancer treatment capacity of an allomaltol derivative from the standpoint of apoptosis and multidrug resistance

ÖNCÜL S., ERCAN A., KARAKAYA G., AYTEMİR M.
FEBS OPEN BIO, 7 - 12 Temmuz 2018, cilt.8, ss.298, (Özet Bildiri) Sürdürülebilir Kalkınma

4. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.
12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Investigation of The Effect of Commercial Herbal Mixture on HepG2 Liver Cancer Cell Line by Proteomic Approach

NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., ÇELEBİER M., HAZNEDAROĞLU İ. C.
12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. Breast Cancer Treatment Capacity of a Allomaltol Derivative from the Standpoint of Apoptosis and Multidrug Resistance

ÖNCÜL S., ERCAN A., KARAKAYA G., AYTEMİR M.
The 43rd FEBS Congress, Prag, Çek Cumhuriyeti, 07 Haziran 2018, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

7. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.
EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)

8. Synthesis of Some New Mannich Bases with Anti-tyrosinase Activity.

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
2nd International Gazi Pharma Symposium Series (GPSS), 11 - 13 Ekim 2017, (Özet Bildiri)

9. MCF-7 Breast Cell Proteome Analysis Determination With New UPLC/MS Method

KOÇAK E., ÖNCÜL S., NENNİ M., kaplan O., ÇELEBİER M., SÜSLÜ İ., et al.
Symposium on Drug Research Development, 5 - 07 Ekim 2017, (Özet Bildiri)

10. Investigation of the Effect of Cyclodextrin Nanoparticles on MCF 7 Breast Cancer Cell Line by Proteomics Approaches

BİLENSOY E., ÇELEBİER M., ERCAN A., NENNİ M., IŞIK G., ÖNCÜL S., et al.
7th BBBB International Conference on Pharmaceutical Sciences, 5 - 07 Ekim 2017, (Tam Metin Bildiri)

11. Screening for Cytotoxic Effects of Chlorokojic Acid Derivatives

AYTEMİR M., Karakaya G., ERCAN A., ÖNCÜL S.
Symposium on Drug Research And Development, 5 - 07 Ekim 2017, (Özet Bildiri)

12. An in vitro investigation of human gingival fibroblast proliferation on dental titanium implants treated with selective laser melting technology

ARİFAĞAOĞLU Ö., ÖNCÜL S., ERCAN A., ERSU B.
26th Annual Scientific Meeting of the European Association for Osseointegration, Madrid, İspanya, 5 - 07 Ekim 2017, cilt.28, ss.26, (Özet Bildiri)

13. Cytotoxic Effect of Allomaltol Derivative on A375 Human Malignant Melanoma and MCF7 Breast Cancer Cells

ERCAN A., AYTEMİR M., KARAKAYA G., ÖNCÜL S.
International Multidisiplinary Symposium on Drug Research Development (DRD2017), 5 - 07 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Screening for Cytotoxic Effects of Chkorokojic Acid Derivatives

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
International Multidisiplinary Symposium on Drug Research Development (DRD2017), 5 - 07 Ekim 2017, (Özet Bildiri) Creative Commons License identifier identifier identifier

15. Mild doses of doxorubicin alters apoptoticresponse and cell cycle arrest on both luminalA and triple negative breast cancer cell lines

ÖNCÜL S., ERCAN A.
42nd FEBS Congress, İsrail, 10 - 14 Eylül 2017, cilt.284, ss.286, (Özet Bildiri) Sürdürülebilir Kalkınma

16. CYTOTOXICITY OF A KOJIC ACID DERIVATIVE ON A375 HUMAN MALIGNANT MELANOMA AND HGF1 FIBROBLAST CELLS

AYTEMİR M., KARAKAYA G., ERCAN A., ÖNCÜL S.
10th Joint Meeting On Medicinal Chemistry, Dubrovnik, Hırvatistan, 25 - 28 Haziran 2017, (Özet Bildiri)

17. Evaluation of Cholesterol-Targeted Amphiphilic Cyclodextrin Nanoparticles for Cancer Therapy

VARAN G., ÖNCÜL S., ERCAN A., BENİTO J., MELLET C. O., BİLENSOY E.
Innovation in Medicine Meetings III Congress, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Assessment of Low Dose Doxorubicin on Apoptosis and Multidrug Resistance in MCF 7 Cells

ERCAN A., ÖNCÜL S.
6. MOKAD, Konya, Türkiye, 27 - 30 Ekim 2016, (Özet Bildiri)
Metrikler

Yayın

37

Yayın (WoS)

20

Yayın (Scopus)

20

Atıf (WoS)

223

H-İndeks (WoS)

6

Atıf (Scopus)

183

H-İndeks (Scopus)

6

Proje

3

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları